You can see reduced or eliminated spider veins with just an injection. Sclerotherapy causes spider veins to collapse and fade, leaving you with more even-toned skin.
In order to locate the root cause of spider vein growth, every patient receives an ultrasound. This painless procedure will identify damaged vessels and is necessary to ensure the proper vessels are targeted and the right treatment is chosen. In many cases, sclerotherapy is the treatment of choice.
During the treatment, a small amount of solution is injected into the damaged veins. The solution causes the vein walls to become sticky and close. Over the next several weeks the body removes the treated vessels. Newer FDA approved solutions, such a Polidocanol, are more effective with fewer side-effects and cause little to no discomfort.
You can request a vein consultation with Dr. Verebelyi by clicking here and filling out the request form. During the consultation, Dr. Verebelyi will be able to assess your unique situation and provide an action plan to move forward.
It is very strongly encouraged, especially if there are bulging veins, swelling, pain or a host of other symptoms.
Yes. The current recommendation is 3 weeks, day and night. We carry a line of stockings in our office, or you can order custom stockings from RejuvaHealth at 1-877-773-5882.
Pain over the injection site, bruising, swelling, itching, blistering, ulceration, and darkening of the skin over the treated area is common and may last up to two years. Other potential risks are an allergic reaction, growth of new blood vessels, vessel recurrence, and in rare cases blood clots, migraine headaches, visual disturbances, and scarring. Patients that have a patent foramen ovale (hole between the right and left chambers of the heart) and those who do not wear appropriate compression after treatment are at increased risk of these side effects.
*Individual results may vary.
DISCOVER OUR BEFORE AND AFTER GALLERY
To request a consultation at Colorado Skin & Vein, call us at (303) 683-3235 or fill out the form below.